Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Investigation

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI40568PMID 20051625PMCID PMC2810087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Short Treatment With an Antibody to Sclerostin Can Inhibit Bone Loss in an Ongoing Model of Colitis

  2009cited by this paper
• Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination.

  2009cited by this paper
• Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

  2009cited by this paper
• gp130 signaling in bone cell biology: multiple roles revealed by analysis of genetically altered mice.

  2009cited by this paper
• Cardiotrophin‐1 Is an Osteoclast‐Derived Stimulus of Bone Formation Required for Normal Bone Remodeling

  2008cited by this paper
• EphrinB2 Regulation by PTH and PTHrP Revealed by Molecular Profiling in Differentiating Osteoblasts

  2008cited by this paper
• Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption.

  2008cited by this paper
• Osteocytes, mechanosensing and Wnt signaling.

  2008cited by this paper
• Role of gp130‐mediated signalling pathways in the heart and its impact on potential therapeutic aspects

  2008cited by this paper
• IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice1

  2008cited by this paper
• Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue‐derived mesenchymal stem cells

  2007cited by this paper
• Bone Morphogenetic Protein 2 Activates Smad6 Gene Transcription through Bone-specific Transcription Factor Runx2*

  2007cited by this paper
• Craniosynostosis‐Associated Gene Nell‐1 Is Regulated by Runx2

  2006cited by this paper
• Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling.

  2006cited by this paper
• CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.

  2006cited by this paper
• Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.

  2006cited by this paper
• Osteoclast-derived activity in the coupling of bone formation to resorption.

  2005cited by this paper
• SOST is a target gene for PTH in bone.

  2005cited by this paper
• Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.

  2005cited by this paper
• Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist

  2004cited by this paper
• Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro.

  2004cited by this paper
• Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

  2004cited by this paper
• Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.

  2004cited by this paper
• Affinity Maturation of Leukemia Inhibitory Factor and Conversion to Potent Antagonists of Signaling*

  2004cited by this paper
• Targeted disruption of oncostatin M receptor results in altered hematopoiesis.

  2003cited by this paper
• Differentiation potential of a mouse bone marrow stromal cell line

  2003cited by this paper
• CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression.

  2002cited by this paper
• IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF-κB Ligand, Osteoprotegerin, and Receptor Activator of NF-κB in Mouse Calvariae1

  2002cited by this paper
• The generation of highly enriched osteoclast-lineage cell populations.

  2002cited by this paper
• Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand.

  2002cited by this paper
• Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.

  2002cited by this paper
• CCAAT/Enhancer-binding Proteins (C/EBP) β and δ Activate Osteocalcin Gene Transcription and Synergize with Runx2 at the C/EBP Element to Regulate Bone-specific Expression*

  2002cited by this paper
• Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).

  2001cited by this paper
• Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.

  2000cited by this paper
• Receptor recognition by gp130 cytokines

  2000cited by this paper
• Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo.

  2000cited by this paper
• Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.

  1999cited by this paper
• Differential Cell Surface Expression of the STRO‐1 and Alkaline Phosphatase Antigens on Discrete Developmental Stages in Primary Cultures of Human Bone Cells

  1999cited by this paper
• Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM).

  1998cited by this paper
• Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.

  1997cited by this paper
• Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow.

  1997cited by this paper
• Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.

  1996cited by this paper
• Oncostatin-M: a new bone active cytokine that activates osteoblasts and inhibits bone resorption.

  1996cited by this paper
• Dual Oncostatin M (OSM) Receptors

  1996cited by this paper
• The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures

  1996cited by this paper
• Modulation of osteoclast differentiation by local factors.

  1995cited by this paper
• Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death.

  1995cited by this paper
• Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 Protein

  1994cited by this paper
• Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

  1993cited by this paper
• Distribution and binding properties of receptors for leukaemia inhibitory factor.

  1992cited by this paper
• Distribution and comparison of receptors for leukemia inhibitory factor on murine hemopoietic and hepatic cells

  1991cited by this paper
• Osteoblasts display receptors for and responses to leukemia‐inhibitory factor

  1990cited by this paper
• Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells.

  1987cited by this paper

• JAK1/STAT3 signalling in cortical bone development, growth and maintenance.

  2026cites this paper
• Recent progress in immunomodulation-based strategies for bone repair

  2025cites this paper
• Isolation, Purification, Generation, and Culture of Osteocytes.

  2025cites this paper
• Iron-lead mixed exposure causes bone damage in mice: A multi-omics analysis.

  2025cites this paper
• Exploring Macrophage Contribution to Vascular Calcification in Atherosclerosis

  2025cites this paper
• Bone marrow neutrophil progenitors suppress osteoclast formation in murine cortical and trabecular bone

  2025cites this paper
• The bone microenvironment: new insights into the role of stem cells and cell communication in bone regeneration

  2025cites this paper
• Hematopoietic effects of Fufang E’jiao Jiang revealed by microbiome, metabolome and transcriptome analyses: a multi-omics strategy

  2025cites this paper
• Single-cell analysis links DCUN1D5 to immune remodeling and cisplatin resistance in recurrent osteosarcoma

  2025cites this paper
• Role and prognostic value of oncostatin M and its receptor OSMR in acute myeloid leukemia, myeloproliferative neoplasms and non-hematological malignancies

  2025cites this paper
• Role of sclerostin in the bone and thyroid metabolism in patients with ovarian polycystic syndrome.

  2025cites this paper
• Oncostatin-M: a novel leukocyte-derived factor facilitating the ovulatory process in the human ovary.

  2025cites this paper
• Human germline biallelic loss-of-function OSMR variants cause severe allergic disease

  2025cites this paper
• Human oncostatin M deficiency underlies an inherited severe bone marrow failure syndrome

  2025cites this paper
• Beyond inflammation: the molecular basis of bone remodeling in axial spondyloarthritis and psoriatic arthritis

  2025influential citation
• Evaluation of sclerostin as a new biomarker in the diagnosis of osteoporosis

  2025cites this paper
• Mechanical force-induced oncostatin M secretion by Jun-positive neutrophils promotes craniofacial bone regeneration for midface hypoplasia treatment

  2025cites this paper
• Cost-Effective Production of Biologically Active Leukemia Inhibitory Factor for Mouse Embryonic Stem Cell Culture.

  2025cites this paper
• Oncostatin-M functionalized cryogel microspheres for promoting diabetic bone defects regeneration

  2025cites this paper
• Development of the First Small-Molecule Inhibitor Targeting Oncostatin M for Treatment of Breast Cancer

  2025cites this paper
• Current perspectives on the multiple roles of osteoclasts: Mechanisms of osteoclast–osteoblast communication and potential clinical implications

  2024cites this paper
• Vitamin A enhanced periosteal osteoclastogenesis is associated with increased number of tissue-derived macrophages/osteoclast progenitors

  2024cites this paper
• Extramedullary hematopoiesis in cancer

  2024cites this paper
• Craniosynostosis‐associated variants in the IL‐11R complex: new insights and questions

  2024cites this paper
• Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation

  2024cites this paper
• The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review

  2024cites this paper
• Preclinical Rodent Models for Human Bone Disease, Including a Focus on Cortical Bone

  2024cites this paper
• Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems

  2024influential citation
• Exploring the Osteogenic Potential of Zinc-Doped Magnesium Phosphate Cement (ZMPC): A Novel Material for Orthopedic Bone Defect Repair

  2024cites this paper
• Osteoclast-derived coupling factors: origins and state-of-play Louis V Avioli lecture, ASBMR 2023

  2024cites this paper
• Oncostatin M receptor-dependent signaling assessed by RNA sequencing in mouse hematopoietic stem cells

  2024cites this paper
• Structures of complete extracellular assemblies of type I and type II Oncostatin M receptor complexes

  2024cites this paper
• Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when.

  2024cites this paper
• Oncostatin M suppresses bone morphogenetic protein‐4‐induced osteoprotegerin synthesis in MC3T3‐E1 osteoblast‐like cells: p70 S6 kinase attenuation

  2024influential citation
• The neutrophil–osteogenic cell axis promotes bone destruction in periodontitis

  2024cites this paper
• Mg-Cross-Linked Alginate Hydrogel Induces BMSC/Macrophage Crosstalk to Enhance Bone Tissue Regeneration via Dual Promotion of the Ligand-Receptor Pairing of the OSM/miR-370-3p-gp130 Signaling Pathway.

  2024cites this paper
• Trained innate immunity modulates osteoblast and osteoclast differentiation

  2024cites this paper
• Oncostatin M is a regulator of fibroblast growth factor 23 (FGF23) in UMR106 osteoblast-like cells

  2023cites this paper
• The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review

  2023influential citation
• Targeting different phenotypes of macrophages: A potential strategy for natural products to treat inflammatory bone and joint diseases.

  2023cites this paper
• Antipsychotic-induced bone loss: the role of dopamine, serotonin and adrenergic receptor signalling

  2023cites this paper
• Extracellular Vesicles: From Bone Development to Regenerative Orthopaedics.

  2023cites this paper
• Oncostatin M stimulates prostaglandin D2-induced osteoprotegerin and interleukin-6 synthesis in osteoblasts.

  2023cites this paper
• Comparative Study of the Cytokine Profiles of Serum and Tissues from Patients with the Ossification of the Posterior Longitudinal Ligament

  2023cites this paper
• Targeting leukemia inhibitory factor in pancreatic adenocarcinoma

  2023cites this paper
• Oncostatin M enhances osteoprotegerin synthesis but reduces macrophage colony‑stimulating factor synthesis in bFGF‑stimulated osteoblast‑like cells.

  2023cites this paper
• The Potential of Natural Compounds Regulating Autophagy in the Treatment of Osteoporosis

  2023cites this paper
• Characterization of an Osmr Conditional Knockout Mouse Model

  2023influential citation
• Loss of hematopoietic cell-derived oncostatin M worsens dietinduced dysmetabolism in mice.

  2023cites this paper
• Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis

  2023cites this paper
• Antisclerostin Effect on Osseointegration and Bone Remodeling

  2023cites this paper
• OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling

  2023cites this paper
• Serum myokines as potential biomarkers of myostatin inhibition in sport doping: a preliminary study on their baseline levels in elite athletes

  2023cites this paper
• The clinical relevance of OSM in inflammatory diseases: a comprehensive review

  2023cites this paper
• Evidence for the major contribution of remodeling-based bone formation in sclerostin-deficient mice.

  2022cites this paper
• Oncostatin M: Risks and benefits of a Novel Therapeutic Target for Atherosclerosis.

  2022cites this paper
• Oncostatin M reduces the synthesis of macrophage-colony stimulating factor stimulated by TGF-β via suppression of p44/p42 MAP kinase and JNK in osteoblasts.

  2022cites this paper
• Targeting 3D chromosomal architecture at the RANK loci to suppress myeloma-driven osteoclastogenesis

  2022cites this paper
• Osteoclasts secrete leukemia inhibitory factor to promote abnormal bone remodeling of subchondral bone in osteoarthritis

  2022cites this paper
• Neurofibromatosis type 2 with mild Pierre-Robin sequence showing a heterozygous chromosome 22q12 microdeletion encompassing NF2 and MN1

  2022influential citation
• Positive and Negative Regulators of Sclerostin Expression

  2022cites this paper
• Contribution of MicroRNA‐27b‐3p to Synovial Fibrotic Responses in Knee Osteoarthritis

  2022cites this paper
• Spatial Organization of Osteoclastic Coupling Factors and Their Receptors at Human Bone Remodeling Sites

  2022influential citation
• Focusing on OB-OC-MΦ Axis and miR-23a to Explore the Pathogenesis and Treatment Strategy of Osteoporosis

  2022cites this paper
• Oncostatin M receptor regulates osteoblast differentiation via extracellular signal-regulated kinase/autophagy signaling

  2022influential citation
• Osteoclasts: Other functions.

  2022cites this paper
• Exogenous Oncostatin M induces Cardiac Dysfunction, Musculoskeletal Atrophy, and Fibrosis.

  2022cites this paper
• HIF-1α Regulates Bone Homeostasis and Angiogenesis, Participating in the Occurrence of Bone Metabolic Diseases

  2022cites this paper
• Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments

  2022cites this paper
• Effects of Vitamin E and Dietary Conditions on the Differentiation and Maturation of Osteoclast.

  2022cites this paper
• The Contribution of Innervation to Tissue Repair and Regeneration.

  2022cites this paper
• Oncostatin M attenuates tumor necrosis factor-α-induced synthesis of macrophage-colony stimulating factor via suppression of Akt in osteoblasts

  2022cites this paper
• Identification of polymorphic loci in OSMR and GHR genes and analysis of their association with growth traits in sheep

  2022cites this paper
• Insights into the Role of Macrophage Polarization in the Pathogenesis of Osteoporosis

  2022cites this paper
• Stimulation of Osteoclast Formation by Oncostatin M and the Role of WNT16 as a Negative Feedback Regulator

  2022influential citation
• Serial Lipocalin 2 and Oncostatin M levels reflect inflammation status and treatment response in axial spondyloarthritis

  2021cites this paper
• Recent Advances in Osteoclast Biological Behavior

  2021cites this paper
• Integrated computational and in vivo models reveal Key Insights into macrophage behavior during bone healing

  2021cites this paper
• The cytokine interleukin-11 crucially links bone formation, remodeling and resorption.

  2021cites this paper
• Dmp1Cre‐directed knockdown of parathyroid hormone–related protein (PTHrP) in murine decidua is associated with a life‐long increase in bone mass, width, and strength in male progeny

  2021cites this paper
• Association between Oncostatin M Expression and Inflammatory Phenotype in Experimental Arthritis Models and Osteoarthritis Patients

  2021influential citation
• Novel insights into the coupling of osteoclasts and resorption to bone formation.

  2021cites this paper
• Mapping the immune microenvironment for mandibular alveolar bone homeostasis at single-cell resolution

  2021cites this paper
• Interleukin 11 (IL-11): Role(s) in Breast Cancer Bone Metastases

  2021cites this paper
• Adipocyte Oncostatin Receptor Regulates Adipose Tissue Homeostasis and Inflammation

  2021cites this paper
• The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer

  2021cites this paper
• STAT3 Hyperactivation Due to SOCS3 Deletion in Murine Osteocytes Accentuates Responses to Exercise‐ and Load‐Induced Bone Formation

  2021influential citation
• Cytokines and the pathogenesis of osteoporosis

  2021cites this paper
• Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR

  2021cites this paper
• gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ Breast Cancer Cells

  2021influential citation
• Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization

  2021cites this paper
• Myeloproliferative Disorders and its Effect on Bone Homeostasis: The Role of Megakaryocytes.

  2021cites this paper
• Association of cardiotrophin-like cytokine factor 1 levels in peripheral blood mononuclear cells with bone mineral density and osteoporosis in postmenopausal women

  2021cites this paper
• WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M

  2021cites this paper
• Modulating immune microenvironment during bone repair using biomaterials: Focusing on the role of macrophages.

  2021cites this paper
• Leukemia inhibitory factor treatment attenuates the detrimental effects of glucocorticoids on bone in mice.

  2021cites this paper
• Emerging roles for IL-6 family cytokines as positive and negative regulators of ectopic lymphoid structures.

  2021cites this paper
• ASPECTS OF INTERCELLULAR COMMUNICATION IN BONE AND IMPLICATIONS IN THERAPY.

  2021cites this paper
• The Crosstalk between Mesenchymal Stem Cells and Macrophages in Bone Regeneration: A Systematic Review

  2021cites this paper
• Prospects of JAK Inhibition in the Framework of Bone Loss

  2021cites this paper